| For: | Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H. Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial. World J Gastroenterol 2024; 30(6): 556-564 [PMID: 38463026 DOI: 10.3748/wjg.v30.i6.556] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i6/556.htm |
| Number | Citing Articles |
| 1 |
Chang Seok Bang, Seung Joo Kang, Hyunchul Lim, Seung Han Kim, Moon Won Lee, Su Youn Nam, Chung Hyun Tae, Sung Eun Kim, Seung Young Kim, Hye-Kyung Jung, Beom Jin Kim, Miyoung Choi, Hwoon-Yong Jung, Byung-Wook Kim. Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2026; 26(2) doi: 10.7704/kjhugr.2026.0029
|
| 2 |
Tehsin Ullah Khan, Mohamed Sharaf, Sohaib Khan, Khurshid Ahmad, Chen-Guang Liu.
Advanced nano-delivery systems in
H. pylori
eradication: targeting, efficacy, and clinical translation
. Expert Opinion on Drug Delivery 2026; 23(1) doi: 10.1080/17425247.2025.2569642
|
| 3 |
Pablo Parra, Olga P. Nyssen, Javier P. Gisbert. Non‐Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis. Helicobacter 2026; 31(1) doi: 10.1111/hel.70099
|
| 4 |
Tianlian Yan, Jinghua Wang, Renke Zhu, Dan Ma, Jianguo Gao, Jiewei Wang, Ye Chen, Kefang Sun, Qing Gu, Lan Li. Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial. Journal of Antimicrobial Chemotherapy 2025; 80(4) doi: 10.1093/jac/dkae467
|
| 5 |
Jad Chidiac, Reine-Marie Kahwaji, Souheil Hallit, Yara Yazbeck, Bassem Akiki, Charbel Yazbeck. A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population. Current Therapeutic Research 2025; 102 doi: 10.1016/j.curtheres.2025.100791
|